Budesonide/formoterol vs budesonide vs formoterol in patients with mild-to-moderate asthma with or without fixed airway obstruction
Phase of Trial: Phase III
Latest Information Update: 22 May 2013
At a glance
- Drugs Budesonide; Budesonide/formoterol; Formoterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms SPRUCE 80/4.5
- Sponsors AstraZeneca
- 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
- 15 Mar 2012 New trial record
- 06 Mar 2012 Results assessing efficacy in patients with versus without fixed airflow obstruction presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.